Latest News - Liechtenstein

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, November 13, 2018

4:49:00 PM CET

Subscribe
RSS

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Country info

LI

Liechtenstein (LI)

All news about Liechtenstein

All news sources from Liechtenstein

LI

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Christoph Lang sagt: „Um gefälschte Arzneimittel künftig auszusondern ist ein Anschluss an Securpharm nötig. Verstöße können mit Bußgeldern und im Extremfall auch mit Entzug der Betriebserlaubnis geahndet werden. Die Apothekenaufsicht im Berliner Landesamt für Gesundheit und Soziales kontrolliert Apotheken regelmäßig, ob sie ihre gesetzlichen Verpflichtungen einhalten“ External link

waz Saturday, November 10, 2018 6:40:00 PM CET

Michael Severino said: "The approval of VENCLYXTO in combination with rituximab is an important step forward in providing patients with relapsed/refractory chronic lymphocytic leukemia a strong chance to live longer without their disease progressing," External link

finanzen-ch Thursday, November 1, 2018 5:33:00 AM CET

Christopher Dembik says: “The greatest capacity to force the hands of a government lies with the markets today,” External link

jamaicaobserver Wednesday, October 31, 2018 6:37:00 AM CET

Olga Feldmeier says: "By building a network of independent issuers of the Swiss Franc stable coin, we ensure that failure of a single issuer does not impose the collapse of the coin, as the CHFt will be accepted by any institution of the network. This massively reduces the counterparty risk connected to a possible failure of a single banking institution," External link

finanzen-ch Monday, October 29, 2018 4:19:00 PM CET

Olga Feldmeier said: "With the CHFt solution we introduce an infrastructure layer for crypto assets that will generate immense value for the digital assets ecosystem. The goal is to build up a network which will promote legitimacy and compliance in the world of digital assets," External link

finanzen-ch Monday, October 29, 2018 4:19:00 PM CET

Olga Feldmeier commented: "We chose Liechtenstein as it allows us to be present in both the Swiss Franc area and the EU banking passporting system. It will allow us to be a first mover in areas vital to the further development of the SMART VALOR platform" External link

finanzen-ch Monday, October 29, 2018 4:19:00 PM CET

Stefania Vallone disse: "O CPNPC ALK+ é uma doença grave e potencialmente fatal, que afeta aproximadamente 40.000 pessoas no mundo inteiro a cada ano, sendo que muitos pacientes irão progredir ou deixar de responder ao tratamento de primeira linha" External link

em Saturday, September 22, 2018 1:08:00 PM CEST

Jesus Gomez disse: "O ensaio ALTA estabeleceu o ALUNBRIG como uma possível opção de tratamento de segunda linha para o CPNPC ALK+, demonstrando eficácia significativa com um perfil de segurança administrável" External link

em Saturday, September 22, 2018 1:08:00 PM CEST

Enriqueta Felip disse: "Embora os inibidores de ALK tenham demonstrado um tremendo crescimento neste período de tratamento durante a última década, outra opção de terapia direcionada disponível para o tratamento de CPNPC ALK+ tem sido aguardada com ansiedade e antecipação" External link

em Saturday, September 22, 2018 1:08:00 PM CEST

Frederic Duchesne disse: "Estamos muito satisfeitos em estar um passo mais perto de levar o BRAFTOVI e o MEKTOVI a pacientes com melanoma mutante BRAF avançado na Europa" External link

em Saturday, July 28, 2018 5:41:00 AM CEST

Themes

Country themes

Daily number of articles in this category

Trend data not available for this selection.